APA

Selaru P., Tang Y., Huang B., Polli A., Wilner K. D., Donnelly E. & Cohen D. P. (20161226). Sufficiency of Single-Arm Studies to Support Registration of Targeted Agents in Molecularly Selected Patients with Cancer: Lessons from the Clinical Development of Crizotinib. : Clinical and translational science.

Chicago

Selaru P, Tang Y, Huang B, Polli A, Wilner K D, Donnelly E and Cohen D P. 20161226. Sufficiency of Single-Arm Studies to Support Registration of Targeted Agents in Molecularly Selected Patients with Cancer: Lessons from the Clinical Development of Crizotinib. : Clinical and translational science.

Harvard

Selaru P., Tang Y., Huang B., Polli A., Wilner K. D., Donnelly E. and Cohen D. P. (20161226). Sufficiency of Single-Arm Studies to Support Registration of Targeted Agents in Molecularly Selected Patients with Cancer: Lessons from the Clinical Development of Crizotinib. : Clinical and translational science.

MLA

Selaru P, Tang Y, Huang B, Polli A, Wilner K D, Donnelly E and Cohen D P. Sufficiency of Single-Arm Studies to Support Registration of Targeted Agents in Molecularly Selected Patients with Cancer: Lessons from the Clinical Development of Crizotinib. : Clinical and translational science. 20161226.